ArticleJournal of the American Chemical Society2026
Base-Free C-N Cross-Electrophile Coupling.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Metal-catalyzed carbon-nitrogen (C-N) cross-coupling─a philicity-matched reaction of carbon electrophiles with nitrogen nucleophiles under basic conditions─is a foundational tool in modern medicinal chemistry. Here, we report a philicity-mismatched nickel-catalyzed C-N cross-electrophile coupling (XEC) that combines electrophilic carbon and nitrogen precursors. Because the method relies on electrophilic nitrogen precursors, basic additives are not required to activate the nitrogen coupling partner. This mild protocol exhibits broad functional group tolerance, including base-sensitive substrates, and is compatible with late-stage applications. The electrophilic nitrogen precursors can be accessed from diverse starting materials, including C-H bonds and olefins. We demonstrate a two-step, one-pot N-phenothiazination, C-N XEC sequence that provides the platform for application of C-N XEC to the functionalization of amine-containing bioactive small molecules. Strategic implementation of C-N XEC enables synthesis of designer secondary and tertiary amines as well as unsymmetrical diamines. Mechanistic investigations indicate the C-N XEC proceeds via a Ni(II)-aryl-amido intermediate and enforces cross-selectivity by avoiding Ni(II)-aryl-halide intermediates associated with homocoupling. These findings establish a paradigm for base-free C-N bond construction and introduce a mechanistic rationale for controlling C-X XEC selectivity.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.